Added to YB: 2026-08-11
Pitch date: 2026-07-08
SDGR [bullish]
Schrödinger, Inc.
+15.72%
current return
Author Info
Outlier Capital is where I share my highest-conviction ideas, portfolio updates, and investment research. Sign up for the newsletter.
Company Info
Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally.
Market Cap
$1.4B
Pitch Price
$16.22
Price Target
170.00 (+836%)
Dividend
N/A
EV/EBITDA
-8.11
P/E
-24.63
EV/Sales
4.06
Sector
Health Care Technology
Category
growth
Healthcare & Biotechnology AI Thesis (I) – 5 Stocks with Credible 10x+ Potential: Schrödinger (SDGR) – Physics + AI Computational Platform for Drug Design (AI-Enabled Biotech)
SDGR: Physics-based molecular simulation + ML for drug design. Dual model: high-margin recurring software (broad biopharma adoption) + internal/co-discovery pipeline. ~$17/share, ~$1.25B cap. 10x+ thesis on software penetration + pipeline/partnership success. Risks: adoption, setbacks, competition.
Read full article (1 min)